These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30878825)

  • 41. SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.
    Tai WT; Hung MH; Chu PY; Chen YL; Chen LJ; Tsai MH; Chen MH; Shiau CW; Boo YP; Chen KF
    Oncotarget; 2016 Apr; 7(16):22193-205. PubMed ID: 26959741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Boronic acid derivative activates pyruvate kinase M2 indispensable for redox metabolism in oral cancer cells.
    Rihan M; Vineela Nalla L; Dharavath A; Patel S; Shard A; Khairnar A
    Bioorg Med Chem Lett; 2022 Mar; 59():128539. PubMed ID: 35007726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.
    Bhardwaj A; Das S
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E538-47. PubMed ID: 26787900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation.
    Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT
    Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of a novel class of dithiocarbamic acid esters as anticancer agent.
    Hou X; Ge Z; Wang T; Guo W; Wu J; Cui J; Lai C; Li R
    Arch Pharm (Weinheim); 2011 May; 344(5):320-32. PubMed ID: 21509804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
    Chen J; Jiang Z; Wang B; Wang Y; Hu X
    Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation.
    Chen TJ; Wang HJ; Liu JS; Cheng HH; Hsu SC; Wu MC; Lu CH; Wu YF; Wu JW; Liu YY; Kung HJ; Wang WC
    Commun Biol; 2019; 2():105. PubMed ID: 30911680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamate-nitrostyrene hybrid as potent antiproliferative and apoptotic inducing agent against cervical cancer cell lines.
    Laskar S; Sánchez-Sánchez L; Flores SM; López-Muñoz H; Escobar-Sánchez ML; López-Ortiz M; Hernández-Rodríguez M; Regla I
    Eur J Med Chem; 2018 Feb; 146():621-635. PubMed ID: 29407986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
    Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
    Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4
    Angiari S; Runtsch MC; Sutton CE; Palsson-McDermott EM; Kelly B; Rana N; Kane H; Papadopoulou G; Pearce EL; Mills KHG; O'Neill LAJ
    Cell Metab; 2020 Feb; 31(2):391-405.e8. PubMed ID: 31761564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives.
    El-Nassan HB
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):308-15. PubMed ID: 24899376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates.
    Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM
    Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.
    Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X
    Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
    Ding PP; Gao M; Mao BB; Cao SL; Liu CH; Yang CR; Li ZF; Liao J; Zhao H; Li Z; Li J; Wang H; Xu X
    Eur J Med Chem; 2016 Jan; 108():364-373. PubMed ID: 26703795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer.
    Liu X; Wang C; Li S; Qu L; Yin F; Lu D; Luo H; Chen X; Luo Z; Cui N; Wang X; Kong L
    J Med Chem; 2021 Dec; 64(23):17304-17325. PubMed ID: 34847663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicomponent synthesis of some new (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamates and their in vitro anti-proliferative activity against CaSki, MDA-MB-231 and SK-Lu-1 tumour cells as apoptosis inducing agents without necrosis.
    Laskar S; Sánchez-Sánchez L; López-Ortiz M; López-Muñoz H; Escobar-Sánchez ML; Sánchez AT; Regla I
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1129-1135. PubMed ID: 28868930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].
    Lü L; Wang L; Jiang GS; Zhang CH; Zeng FQ
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):102-6. PubMed ID: 23441447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dithiocarbamation of spiro-aziridine oxindoles: a facile access to C3-functionalised 3-thiooxindoles as apoptosis inducing agents.
    Sakla AP; Panda B; Laxmikeshav K; Soni JP; Bhandari S; Godugu C; Shankaraiah N
    Org Biomol Chem; 2021 Dec; 19(48):10622-10634. PubMed ID: 34870311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.